S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.86 (-0.06%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.86 (-0.06%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.86 (-0.06%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.86 (-0.06%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
NYSE:A

Agilent Technologies - A Stock Forecast, Price & News

$132.38
-1.52 (-1.14%)
(As of 08/16/2022 12:21 PM ET)
Add
Compare
Today's Range
$131.67
$134.26
50-Day Range
$112.71
$134.56
52-Week Range
$112.52
$179.57
Volume
21,823 shs
Average Volume
1.28 million shs
Market Capitalization
$39.54 billion
P/E Ratio
31.90
Dividend Yield
0.63%
Price Target
$152.75

Agilent Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
14.1% Upside
$152.75 Price Target
Short Interest
Healthy
1.01% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.14
Upright™ Environmental Score
News Sentiment
0.17mentions of Agilent Technologies in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$867,781 Sold Last Quarter
Proj. Earnings Growth
9.63%
From $4.88 to $5.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.05 out of 5 stars

Computer And Technology Sector

45th out of 664 stocks

Analytical Instruments Industry

2nd out of 31 stocks

A stock logo

About Agilent Technologies (NYSE:A) Stock

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Truist Financial downgraded shares of Agilent Technologies from a "buy" rating to a "hold" rating in a report on Tuesday, April 19th. StockNews.com raised shares of Agilent Technologies from a "buy" rating to a "strong-buy" rating in a report on Wednesday, August 3rd. KeyCorp cut their price target on shares of Agilent Technologies from $195.00 to $155.00 and set an "overweight" rating for the company in a report on Thursday, June 2nd. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $160.00 to $130.00 and set an "equal weight" rating for the company in a report on Monday, April 25th. Finally, UBS Group started coverage on shares of Agilent Technologies in a report on Wednesday, July 20th. They set a "buy" rating and a $139.00 price target for the company. Four research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $152.75.

Agilent Technologies Price Performance

NYSE:A traded down $0.88 on Tuesday, hitting $133.02. The company had a trading volume of 2,046 shares, compared to its average volume of 1,284,865. The stock has a market capitalization of $39.73 billion, a price-to-earnings ratio of 32.27, a PEG ratio of 2.74 and a beta of 1.06. The company has a current ratio of 2.01, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. The firm has a 50 day moving average of $123.23 and a two-hundred day moving average of $127.54. Agilent Technologies has a 52 week low of $112.52 and a 52 week high of $179.57.

Agilent Technologies (NYSE:A - Get Rating) last issued its quarterly earnings data on Tuesday, May 24th. The medical research company reported $1.13 EPS for the quarter, beating the consensus estimate of $1.11 by $0.02. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.62 billion. During the same quarter in the prior year, the firm earned $0.97 EPS. The firm's revenue was up 5.4% compared to the same quarter last year. On average, research analysts anticipate that Agilent Technologies will post 4.88 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th were given a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 0.63%. The ex-dividend date of this dividend was Friday, July 1st. Agilent Technologies's dividend payout ratio (DPR) is currently 20.24%.

Insider Buying and Selling at Agilent Technologies

In other news, VP Jacob Thaysen sold 5,879 shares of the stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the sale, the vice president now directly owns 88,737 shares in the company, valued at $11,307,755.91. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, VP Padraig Mcdonnell sold 1,000 shares of the stock in a transaction on Thursday, June 30th. The shares were sold at an average price of $118.62, for a total transaction of $118,620.00. Following the completion of the sale, the vice president now directly owns 17,826 shares in the company, valued at $2,114,520.12. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Jacob Thaysen sold 5,879 shares of the stock in a transaction on Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total transaction of $749,160.97. Following the transaction, the vice president now directly owns 88,737 shares in the company, valued at $11,307,755.91. The disclosure for this sale can be found here.

Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Stock News Headlines

Fortive (FTV) Tops Q2 Earnings and Revenue Estimates
Agilent Technologies (NYSE:A) Shares Up 6.1%
Agilent Technologies (NYSE:A) Now Covered by UBS Group
Halo Labs Completes $6M Series C Growth Financing
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Company Calendar

Last Earnings
5/24/2022
Ex-Dividend for 7/27 Dividend
7/01/2022
Dividend Payable
7/27/2022
Today
8/16/2022
Next Earnings (Confirmed)
8/16/2022
Fiscal Year End
10/31/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
17,000
Year Founded
1999

Price Target and Rating

Average Stock Price Forecast
$152.75
High Stock Price Forecast
$185.00
Low Stock Price Forecast
$130.00
Forecasted Upside/Downside
+15.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$1.21 billion
Pretax Margin
21.86%

Debt

Sales & Book Value

Annual Sales
$6.32 billion
Cash Flow
$5.43 per share
Book Value
$17.84 per share

Miscellaneous

Free Float
N/A
Market Cap
$39.54 billion
Optionable
Optionable
Beta
1.06

Social Links















A Stock - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price forecast for 2022?

13 brokerages have issued twelve-month price objectives for Agilent Technologies' shares. Their A share price forecasts range from $130.00 to $185.00. On average, they expect the company's stock price to reach $152.75 in the next year. This suggests a possible upside of 14.1% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2022?

Agilent Technologies' stock was trading at $159.65 at the beginning of the year. Since then, A shares have decreased by 16.1% and is now trading at $133.90.
View the best growth stocks for 2022 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 3,010,000 shares, a decrease of 6.5% from the July 15th total of 3,220,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.0% of the company's stock are short sold.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 16th 2022.
View our A earnings forecast
.

How can I listen to Agilent Technologies' earnings call?

Agilent Technologies will be holding an earnings conference call on Tuesday, August 16th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings data on Tuesday, May, 24th. The medical research company reported $1.13 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.02. The medical research company earned $1.61 billion during the quarter, compared to the consensus estimate of $1.62 billion. Agilent Technologies had a trailing twelve-month return on equity of 27.42% and a net margin of 19.35%. Agilent Technologies's revenue was up 5.4% on a year-over-year basis. During the same period last year, the firm earned $0.97 EPS.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, May 18th. Shareholders of record on Tuesday, July 5th will be paid a dividend of $0.21 per share on Wednesday, July 27th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date is Friday, July 1st.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.63%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 20.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.70% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies declared that its Board of Directors has authorized a share buyback program on Tuesday, February 16th 2021, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 5% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its stock is undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies issued an update on its FY 2022 earnings guidance on Tuesday, June, 21st. The company provided earnings per share (EPS) guidance of $4.86-$4.93 for the period, compared to the consensus earnings per share estimate of $4.60. The company issued revenue guidance of $6.67 billion-$6.73 billion, compared to the consensus revenue estimate of $6.36 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include State Street Corp (4.38%), Massachusetts Financial Services Co. MA (1.96%), Pictet Asset Management SA (1.83%), Northern Trust Corp (1.41%), Cantillon Capital Management LLC (1.16%) and FMR LLC (1.14%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $133.90.

How much money does Agilent Technologies make?

Agilent Technologies (NYSE:A) has a market capitalization of $40.00 billion and generates $6.32 billion in revenue each year. The medical research company earns $1.21 billion in net income (profit) each year or $4.15 on an earnings per share basis.

How many employees does Agilent Technologies have?

The company employs 17,000 workers across the globe.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
When was Agilent Technologies founded?

Agilent Technologies was founded in 1999.

How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.

This page (NYSE:A) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.